Recent research revealed that lower leptin levels in PAH patients, corrected by BMI, were associated with an increased overall mortality and the leptin/BMI ratio represented a negative predictive value for mortality at two years [16]. This evidence concerns the gene LEP and pulmonary arterial hypertension.